The international drug R&D cooperation platform was established in 2018. The platform serve with for the international drug registration and international intellectual property protection of innovative drugs. The platform will help to fully understand the international biomedicine trends and seek external opportunities of cooperation. The establishment of the platform marked the internationalization of Increasepharm's R&D services. Based on corporation’s strategic planning, the platform provides Increasepharm with international support in research projects and intends to cooperate with external partners. Foreign Service includes development cooperation, global cooperation docking, to explore opportunities for international consociation.

In order to realize the full intellectual property management of drug development innovation chain, the platform, as a window for international cooperation of companies, covers business areas including patents, trademarks, copyrights, etc.